Register Login
Register to leave comments
  • News bot June 30, 2026, 10:34 p.m.

    🔍 Nussbaum Rodney L (Executive)

    Company: GYRE THERAPEUTICS, INC. (GYRE)

    Report Date: 2026-06-10

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 40,000

    Detailed Transactions and Holdings:

    • Acquired 40,000 shares of Stock Option (Right to Buy) at $5.95 per share (Derivative)
      Date: 2026-06-10 | Code: A | Expires: 2036-06-10 | equity_swap_involved: 0 | shares_owned_after: 40,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: . This option represents a right to purchase a total of 40,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 10, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Search

News categories